• CCO
• Oncology
• Live Events
• Role of Anthracyclines in EBC

Hilton Palacio del Rio Hotel
Salon del Rey
4th Floor Mezzanine  
200 South Alamo Street
San Antonio, Texas

Thank you for your interest in this live program. Registration is closed, as the current schedule has been completed. Please email info@clinicaloptions.com for more information.

Key opinion leaders present data, describe clinical cases, and participate in a debate of one of the greatest controversies today in the management of early breast cancer: when to use anthracycline- or nonanthracycline-containing regimens in patients with breast cancer. HER2-positive and HER2-negative cases will be explored.

• Agenda
• Faculty
• CME Information
• Accreditation

Program Chair

Fran Visco, JD
President, National Breast Cancer Coalition Foundation
Washington, DC

Faculty

Mark Levine, MD
Professor and Chair, Department of Oncology
McMaster University
Hamilton, Ontario

Dennis J. Slamon, MD, PhD

Chief, Division of Hematology/Oncology
David Geffen School of Medicine at UCLA
Los Angeles, California

Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.